The University of Kansas Hospital

Westwood, Kansas 66205

1 studies enrolling now · 3 studies all time

What they study most

High-risk Large B-cell Lymphoma (LBCL), Relapsed/Refractory Follicular Lymphoma, Triple Negative Breast Cancer

Studies at this site

• A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer — Recruiting now
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma — Running, not enrolling